Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

A Few Stocks to Build Around as an Infrastructure Package Progresses

These companies should benefit should Congress finally pass a measure to promote more infrastructure spending.

Politics Are Impacting Markets in a Number of Ways

There are at least three key political questions playing out.

Taking Another Look at 2 Stocks I Like While Waiting for Breadth to Broaden

Recent news about Travelzoo and Albireo Pharma offer reasons to think those shares could be heading higher.

2 'Off the Radar' Names to Consider

Insiders have been adding to their stakes in Greenbrier Cos and Ring Energy.

Look for COVID Concerns to Continue to Drive Market Action

It would not be surprising to see this seesaw action repeatedly in the months ahead.

I'm Happily Keeping My Covered Call Options Rolling, Rolling, Rolling

The simple strategy may not make for home runs but is producing a number of singles and doubles in a dicey market.

Looking to Get Back in on the Housing Sector, Here's My Plan

With a recent pullback in these stocks I am looking for strategic re-entry points.

Inflation Likely Isn't Abating, So Seek Stocks That Should Benefit From It

One such name is GrafTech International, which should be aided by a rebound in spot graphite electrode pricing.

2 Small Stocks to Watch as Conditions Ripen for Biotech Merger Deals

Ardelyx Inc. and Rigel Pharmaceuticals look good as stand-alone companies but also could attract suitors.

Yields Continue Their Perplexing Fall

The action in Treasuries is just one more reason to be cautious about equities at current trading levels.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight